Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cosmos Health (COSM) Cash & Equivalents (2016 - 2025)

Cosmos Health (COSM) has disclosed Cash & Equivalents for 13 consecutive years, with $889441.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cash & Equivalents fell 73.17% year-over-year to $889441.0, compared with a TTM value of $889441.0 through Sep 2025, down 73.17%, and an annual FY2024 reading of $315105.0, down 91.78% over the prior year.
  • Cash & Equivalents was $889441.0 for Q3 2025 at Cosmos Health, up from $655503.0 in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $20.7 million in Q4 2022 and bottomed at $286487.0 in Q4 2021.
  • Average Cash & Equivalents over 5 years is $2.8 million, with a median of $865099.0 recorded in 2024.
  • The sharpest move saw Cash & Equivalents skyrocketed 7142.8% in 2022, then crashed 92.81% in 2024.
  • Year by year, Cash & Equivalents stood at $286487.0 in 2021, then surged by 7142.8% to $20.7 million in 2022, then plummeted by 81.53% to $3.8 million in 2023, then tumbled by 91.78% to $315105.0 in 2024, then skyrocketed by 182.27% to $889441.0 in 2025.
  • Business Quant data shows Cash & Equivalents for COSM at $889441.0 in Q3 2025, $655503.0 in Q2 2025, and $742881.0 in Q1 2025.